Medicines recall

EL(25)A/02

Issued on 13 Jan 2025 · source: MHRA — Medicines and Healthcare products Regulatory Agency

Class 4 recall

Check the batch number on the pack. The medicine remains licensed; other batches are not affected.

Class 4 recall · DMRC 34132023 · licence holder: Irbesartan 150 mg and 300 mg film-coated tablets

MHRA alert on GOV.UK ↗ All events: EL(25)A/02

What this means

The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.

Class 4 recall · DMRC 34132023

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.